| Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. (NCT03212131) | Novo Nordisk A/S | 2017-08-16 |
| Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function (NCT03186495) | Novo Nordisk A/S | 2017-06-20 |
| Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency (NCT02616562) | Novo Nordisk A/S | 2016-03-31 |
| A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency (NCT02382939) | Novo Nordisk A/S | 2015-02-12 |
| Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD) (NCT02005198) | Novo Nordisk A/S | 2014-03-01 |
| A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency (NCT01973244) | Novo Nordisk A/S | 2013-12-16 |
| A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency (NCT01706783) | Novo Nordisk A/S | 2012-10-12 |
| First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects (NCT01514500) | Novo Nordisk A/S | 2012-01-16 |
| Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone (NCT01327924) | Novo Nordisk A/S | 2011-04-01 |
| Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents (NCT01245374) | Novo Nordisk A/S | 2010-11-01 |
| An Observational Study on Treatment Compliance by Children Treated With Growth Hormone (NCT01068639) | Novo Nordisk A/S | 2010-02-01 |
| Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency (NCT01109017) | Novo Nordisk A/S | 2009-10-01 |
| A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone (NCT00936403) | Novo Nordisk A/S | 2009-08-01 |
| An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin® (NCT00934063) | Novo Nordisk A/S | 2009-07-01 |
| Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 (NCT00722540) | Novo Nordisk A/S | 2008-07-01 |
| Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 (NCT00715689) | Novo Nordisk A/S | 2008-07-01 |
| Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® (NCT01034202) | Novo Nordisk A/S | 2007-08-01 |
| Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ (NCT01500486) | Novo Nordisk A/S | 2007-01-01 |
| Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128) | Novo Nordisk A/S | 2006-04-01 |
| Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (NCT01604161) | Novo Nordisk A/S | 2005-05-01 |
| Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) (NCT00184730) | Novo Nordisk A/S | 2004-11-01 |
| Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) (NCT00184743) | Novo Nordisk A/S | 2003-12-06 |
| French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin (NCT01580605) | Novo Nordisk A/S | 2003-07-17 |
| Safety and Efficacy of Long-term Somatropin Treatment in Adults (NCT01543880) | Novo Nordisk A/S | 2003-07-01 |
| Growth Hormone Deficiency in Adults (GHDA) (NCT00519558) | Novo Nordisk A/S | 2003-05-31 |
| Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children (NCT00102817) | Novo Nordisk A/S | 2003-05-01 |
| Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT00567385) | Novo Nordisk A/S | 2003-03-10 |
| An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) (NCT01009905) | Novo Nordisk A/S | 2002-06-24 |
| Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency (NCT00184678) | Novo Nordisk A/S | 2002-02-01 |
| Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency (NCT01698944) | Novo Nordisk A/S | 2001-05-16 |
| Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency (NCT01502124) | Novo Nordisk A/S | 2001-05-08 |
| Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867) | Novo Nordisk A/S | 2001-01-01 |
| Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT01563926) | Novo Nordisk A/S | 2000-10-23 |
| Effect of Growth Hormone in Children With Growth Hormone Deficiency (NCT00262249) | Novo Nordisk A/S | 2000-08-01 |
| A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin (NCT00931476) | Novo Nordisk A/S | 2000-04-06 |
| Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients (NCT01562834) | Novo Nordisk A/S | 1998-10-21 |